Font Size: a A A
Keyword [Myeloma]
Result: 141 - 160 | Page: 8 of 10
141. The Experimental And Clinical Research Of Arsenic Trioxide Therapeutic Effects On Multiple Myeloma
142. The Induction Of DCs From Multiple Myeloma Patients In Vitro And Study Of Its Biological Characteristics
143. The Effects Of Drugs On The Abnormal Expressions Of Multiple Cytokines Of Mesenchymal Stem Cells In Patients With Multiple Myeloma
144. The Study Of The Lethal Effect Of Cytotoxic Lymphocyte Against U266 Cells Induced By DCs Modified With Gene And Pulsed With Antigen.
145. Effect Of Vascular Endothelial Growth Factor Antisense RNA On Myeloma Cell U266 Growth And Its Angiogenesis
146. A Study Of The Expression Of MUC1 Gene In Hematological Malignant Diseases And Its Clinical Significance
147. The Clinical Value Of Peripheral Blood Plasma Cells In Patients With Multiple Myeloma
148. Clinical Analysis Of Patients With Light-chain MultiplMyeloma
149. The Efficacy Observation Of VAD Regimen In The Treatment Of Multiple Myeloma
150. The Clinical Use Of Cystatin C In Patients With My Eloma
151. Clinical Study Of New Therapy For Relapsed/refractory Multiple Myeloma
152. The Expression Of Regulatory T Cells In Peripheral Blood Mononuclear Cells From Patients With Multiple Myeloma And Its Potential Clinical Significance
153. The Clinical Value Of Plasmaphresis In The Treatment Of Multiple Myeloma
154. Interference Of Arsenic Trioxide And Dexamethasone In Proliferation Of Multiple Myeloma Cell Promoted By SDF-1
155. The Related Antigens Between SP2/0 Myeloma Cell And Trichinella Spiralis
156. Treatment Of Newly Diagnosed Multiple Myeloma Based On Bortezomib Plus Dexamethasone
157. Prognostic Analysis Of Prognostic Factors And Assessment On The Clinical Staging Systems Of Multiple Myeloma
158. Clinic Trial And The Mechanism Of Arsenic Trioxide-Based Chemotherapy In Patients With Non-Hodgkin Lymphoma Or Multiple Myeloma
159. A Study Of MUC1 In Multiple Myeloma And B-Non-Hodgkin's Lymphoma
160. Studies On The Methylation Of DAZAP2 Promoter And Its Down-regulation In Multiple Myeloma
  <<First  <Prev  Next>  Last>>  Jump to